Ability of the VITEK 2 Advanced Expert System To Identify β-Lactam Phenotypes in Isolates of Enterobacteriaceae andPseudomonas aeruginosa
暂无分享,去创建一个
Kenneth S. Thomson | M. Peyret | E. S. Moland | K. Thomson | Ellen Smith Moland | Christine C. Sanders | Michel Peyret | Carole Shubert | Jean-Marc Boeufgras | W. Eugene Sanders | C. Sanders | W. Sanders | J. Boeufgras | C. Shubert | W. Sanders
[1] Christine C. Sanders,et al. β-Lactam Resistance in Gram-Negative Bacteria: Global Trends and Clinical Impact , 1992 .
[2] G. Jacoby,et al. A functional classification scheme for beta-lactamases and its correlation with molecular structure , 1995, Antimicrobial agents and chemotherapy.
[3] C. Sanders,et al. Heterogeneity of class I beta-lactamase expression in clinical isolates of Pseudomonas aeruginosa , 1988, Antimicrobial Agents and Chemotherapy.
[4] Kenneth S. Thomson,et al. Can Results Obtained with Commercially Available MicroScan Microdilution Panels Serve as an Indicator of β-Lactamase Production among Escherichia coli andKlebsiella Isolates with Hidden Resistance to ExpandedSpectrum Cephalosporins and Aztreonam? , 1998, Journal of Clinical Microbiology.
[5] A. Medeiros,et al. Evolution and dissemination of β-lactamases accelerated by generations of β-lactam antibiotics , 1997 .
[6] C. O'callaghan,et al. Effects of beta-lactamase from gram-negative organisms on cephalosporins and penicillins. , 1968, Antimicrobial agents and chemotherapy.
[7] A. Harris,et al. The use of analytical isoelectric focusing for detection and identification of beta-lactamases. , 1975, Journal of general microbiology.
[8] Mary Jane Ferraro,et al. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically : approved standard , 2000 .
[9] E. S. Moland,et al. Characterization of beta-lactamases in situ on polyacrylamide gels , 1986, Antimicrobial Agents and Chemotherapy.
[10] H. Goossens,et al. Comparison of screening methods for detection of extended-spectrum beta-lactamases and their prevalence among blood isolates of Escherichia coli and Klebsiella spp. in a Belgian teaching hospital , 1997, Journal of clinical microbiology.
[11] E. S. Moland,et al. Use of Microdilution Panels with and without β-Lactamase Inhibitors as a Phenotypic Test for β-Lactamase Production among Escherichia coli, Klebsiella spp.,Enterobacter spp., Citrobacter freundii, andSerratia marcescens , 1999, Antimicrobial Agents and Chemotherapy.
[12] J. Waitz. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically , 1990 .
[13] C. Sanders. beta-Lactamases of gram-negative bacteria: new challenges for new drugs. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[14] J. Sambrook,et al. Molecular Cloning: A Laboratory Manual , 2001 .
[15] D. Livermore. beta-Lactamases in laboratory and clinical resistance , 1995, Clinical microbiology reviews.
[16] A L Barry,et al. Detection of extended-spectrum-beta-lactamase-producing members of the family Enterobacteriaceae with Vitek ESBL test , 1996, Journal of clinical microbiology.
[17] P. Bradford,et al. Development of test panel of beta-lactamases expressed in a common Escherichia coli host background for evaluation of new beta-lactam antibiotics , 1995, Antimicrobial agents and chemotherapy.
[18] E. Bruck,et al. National Committee for Clinical Laboratory Standards. , 1980, Pediatrics.